United States Endoscopy Device Market Outlook
The United States endoscopy device market is projected to reach a valuation of around USD 17.41 billion by 2030, according to Renub Research. Endoscopy devices have revolutionized the healthcare industry by providing minimally invasive tools for diagnosis and treatment across various medical specialties. These devices allow visual examinations and interventions within internal organs, leading to reduced patient discomfort and quicker recovery times. The widespread adoption of endoscopy in the United States is evident, with hundreds of thousands of procedures performed annually for various conditions, including gastrointestinal and respiratory disorders. Technological advancements, such as high-definition imaging and enhanced therapeutic capabilities, continue to drive the evolution of endoscopy.
Market Growth Factors
The United States endoscopy device market is expected to grow at a Compound Annual Growth Rate (CAGR) of 6.06% between 2024 and 2030. One key factor driving this growth is the rising prevalence of brain and spinal cord tumors. According to the American Cancer Society, approximately 24,810 malignant brain or spinal cord tumors are projected to be diagnosed in 2023. Endoscopes, with their minimally invasive approach, are essential for diagnosing and treating these conditions, allowing surgeons to perform precise interventions in delicate neural structures. This increased demand for advanced endoscopic techniques is expected to significantly boost the market.
Technological advancements are also propelling the growth of the United States endoscopy device market. Innovations such as high-definition imaging, miniaturization, and enhanced therapeutic capabilities improve the precision and efficiency of endoscopic procedures. These advancements allow healthcare providers to perform complex diagnostic and therapeutic tasks with greater accuracy and patient comfort, fueling demand for advanced endoscopic systems. As a result, the United States endoscopy device market was valued at USD 11.53 billion in 2023.
Request for free Sample Report: https://www.renub.com/request-sample-page.php?gturl=united-states-endoscopy-devices-market-p.php
Government Initiatives and Strategic Trends
Government agencies are increasingly supporting innovations to improve endoscope safety and prevent infections. In April 2022, the U.S. Food and Drug Administration (FDA) recommended that hospitals and endoscopy centers transition to new, modern duodenoscope designs to address reprocessing and cross-contamination concerns. Companies operating in this market are driving growth through product approvals, strategic partnerships, and acquisitions, expanding their endoscopy offerings.
Product and Application Segmentation
By product type, the United States endoscopy device market is fragmented into endoscopes, visualization and documentation systems, mechanical endoscopic equipment, accessories, and other endoscopy equipment. Endoscopes are a leading product type due to their versatility and extensive application across various clinical specialties. These devices allow for minimally invasive procedures in gastrointestinal, respiratory, and urinary systems, with continuous technological improvements enhancing their functionality.
By application, the market is segmented into bronchoscopy, arthroscopy, laparoscopy, urology endoscopy, neuroendoscopy, gastrointestinal endoscopy, gynecology endoscopy, ENT endoscopy, and others. Gastrointestinal endoscopy is one of the most widely used applications, facilitating the diagnosis and treatment of digestive disorders like ulcers, polyps, and cancers. The ability to provide precise visualization and therapeutic capabilities makes gastrointestinal endoscopy a key driver in the U.S. endoscopy device market.
Single-Use Devices and Key End-Users
By hygiene, the United States endoscopy device market is categorized into single-use, reprocessing, and sterilization. Single-use endoscopy devices are gaining traction due to their inherent benefits in infection control and convenience. These devices eliminate the need for reprocessing, reducing cross-contamination risks and streamlining workflows. The increased focus on patient safety and healthcare-associated infection reduction is driving the adoption of single-use devices.
By end-user, the market is segmented into hospitals, ambulatory surgery centers, and others. Hospitals represent a significant segment due to their large patient volume and diverse medical specialties. Endoscopic procedures are routinely performed across various departments in hospitals, emphasizing the need for advanced endoscopic systems to meet the diverse clinical requirements.
Geographic Insights
By state, the United States endoscopy device market is divided into California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio, Georgia, New Jersey, Washington, North Carolina, Massachusetts, Virginia, Michigan, and other states. California is a leading state in the market, thanks to its robust healthcare infrastructure, technological innovation, and large population. The state hosts numerous medical facilities and research establishments, fostering a favorable environment for adopting advanced endoscopy technologies.
Key Players
Major companies in the United States endoscopy device market include Johnson & Johnson, Stryker, Boston Scientific, CONMED, Medtronic Plc, Fujifilm Holdings, and Smith & Nephew. These companies are at the forefront of innovation, manufacturing high-quality endoscopy devices, and driving the evolution of the endoscopy market in the United States.
Recent developments in the market include:
- In February 2023, Boston Scientific Corporation received FDA approval for the LithoVue Elite Single-Use Digital Flexible Ureteroscope System, designed to monitor intrarenal pressure in real-time during ureteroscopy procedures.
- In January 2023, UC Davis Health opened a new, larger endoscopy suite featuring advanced technology and integrated care to accommodate the growing demand for endoscopic procedures.
Overall, the United States endoscopy device market is poised for continued growth, driven by technological advancements, increasing demand for minimally invasive procedures, and strategic government and industry initiatives to improve patient outcomes and safety.
About the Company:
Renub Research is a Market Research and Information Analysis company with more than 15 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 9000 syndicated reports and worked on more than 750 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.
Media Contact:
Company Name: Renub Research
Contact Person: Rajat Gupta, Marketing Manager
Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)
Address: 225 Kristie Ln, Roswell, GA 30076
Email: info@renub.com
LinkedIn: https://linkedin.com/company/renub-research
Website: www.renub.com
